Tolerance Bio, Inc.
PrivateLast Round
Seed
Dec 20, 2024
Total Funding Raised
$20.2M
Company Overview
Tolerance Bio, Inc. is a biopharmaceutical company developing therapies focused on manipulating immune tolerance via the thymus to address various immune-mediated diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B2C
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tolerance Bio, Inc. Comps
Public and private peers based on sector, stage, and business model.
Tolerance Bio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 20, 2024 |
Key People
Founding team and executive leadership
Tolerance Bio, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pacific 8 Ventures | Seed |
| Benjamin Franklin Technology Partners | Seed |
| Criteria Bio Ventures | Seed |
| Sessa Capital | Seed |
| BioAdvance Capital | Seed |
| Columbus Venture Partners | Seed |
Tolerance Bio, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Tolerance Bio, Inc.'s valuation, stock price, and market status.
